Sfoglia per Autore
catalisi enantioselettiva : sintesi di istidina non naturale e istidina non naturale deuterata
2006 E. Cesarotti, I. Rimoldi, P. Spalluto, D. Zerla
difosfine chelanti innovative e loro applicazioni in catalisi asimmetrica.
2006 E. Cesarotti, I. Rimoldi, P. Spalluto, D. Zerla
Natural, unnatural and D2 labelled aminoacids by asymmetric hydrogenation
2007 E. Cesarotti, I. Rimoldi, D. Zerla
Histidine and deuterium labelled histidine by asymmetric catalytic reduction
2007 D. Zerla, E. Cesarotti
Histidine and deuterium labelled histidine by asymmetric catalytic reduction with gaseous H-2 or D-2 : the role of strong non-coordinating acids
2008 E. Cesarotti, I. Rimoldi, D. Zerla, G. Aldini
Natural and unnatural aminoacids by catalytic reduction with Rh(I)-diphosphine complexes; role of strong acids in the synthesis of deuterium labelled histidine.
2008 D. Zerla, E. Cesarotti
Asymmetric Hydrogenation of prochiral Ketones catalyzed by Ru(II)Cl2diphosphine/diamine system
2008 P. Spalluto, E. Cesarotti, I. Rimoldi, D. Zerla
Hystidine and deuterium labelled hystidine by catalytic reduction with Rh(I)-diphosphine complexes and non coordinating strong acids.
2008 E. Cesarotti, I. Rimoldi, D. Zerla
ZedPhos Ru(II)/Diamine complexes in asymmetric reduction of carbonyl groups.
2008 P. Spalluto, E. Cesarotti, I. Rimoldi, D.S. Zerla
Synthesis of chiral bioactive molecules by Catalytic Asymmetric Reduction
2009 D.S. Zerla
Histidine and deuterium-labelled histidine by asymmetric catalytic reduction and assignment of the absolute stereochemistry by neutron diffraction
2010 A. Albinati, E. Cesarotti, S.A. Mason, I. Rimoldi, S. Rizzato, D.S. Zerla
Asymmetric reduction by transition metals complexes and biocatalysts
2010 I. Rimoldi, E. Cesarotti, F.E. Molinari, D. Romano, D.S. Zerla, R. Gandolfi
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer
2010 E. Cesarotti, I. Rimoldi, D.S. Zerla
Chemo- and biocatalytic strategies to obtain phenylisoserine, lateral chain of taxol by asymmetric reduction
2011 I. Rimoldi, M. Pellizzoni, G. Facchetti, F.E. Molinari, D.S. Zerla, R. Gandolfi
3-(Hydroxy(phenyl)methyl)azetidin-2-ones obtained via catalytic asymmetric hydrogenation or by biotransformation
2011 I. Rimoldi, E. Cesarotti, D. Zerla, F. Molinari, D. Albanese, C. Castellano, R. Gandolfi
Enantioselective transfer hydrogenation of aryl ketones: synthesis and 2D-NMR characterization of new 8-amino-5,6,7,8-tetrahydroquinoline Ru(II)-complexes
2012 I. Rimoldi, G. Facchetti, E. Cesarotti, M. Pellizzoni, M. Fusè, D.S. Zerla
“In situ” Activation of Racemic RuII Complexes: Separation of trans and cis Species and Their Application in Asymmetric Reduction
2012 G. Facchetti, E. Cesarotti, M. Pellizzoni, D. Zerla, I. Rimoldi
"In situ" activation of racemic Ru(II) complexes : separation of trans and cis species and their application in asymmetric reduction
2012 G. Facchetti, E. Cesarotti, M. Pellizzoni, D. Zerla, I. Rimoldi
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer
2012 M. Pellizzoni, G. Facchetti, E. Cesarotti, I. Rimoldi, D. Zerla
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin
2013 N. Ferri, S. Cazzaniga, L. Mazzarella, G. Curigliano, G. Lucchini, D. Zerla, R. Gandolfi, G. Facchetti, M. Pellizzoni, I. Rimoldi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile